Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lung Diseases × lorlatinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 12 Recurrence 3 Non Small Cell Lung Cancer Metastatic 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Meningeal Carcinomatosis 2 Brain Neoplasms 2 Thrombocytosis 1 Sexual Dysfunction, Physiological 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoadjuvant Non-Small Cell Lung Cancer 1 NSCLC 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Carboplatin 9 Paclitaxel 5 Nivolumab 4 Cisplatin 3 atezolizumab 2 apatinib 2 Pemetrexed 2 One-Lung Ventilation 2 Ipilimumab 2 Blood Specimen Collection 2 Bevacizumab 2 zimberelimab 1 toripalimab 1 spartalizumab 1 sitravatinib 1 sintilimab 1 sacituzumab govitecan 1 pembrolizumab 1 lorlatinib 1 cemiplimab 1 camrelizumab 1 Vital Signs 1 Tyrosine Kinase Inhibitors 1 Tomography, Emission-Computed, Single-Photon 1 Temozolomide 1 Telescopes 1 Talc 1 Surveys and Questionnaires 1 Saline Solution 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05167500 2023-03-30

LORLAPULM

Fundación GECP

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡